Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

NCT05534854 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05534854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05534854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
August 1, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alk gene mutation, bap1 tumor predisposition syndrome, birt-hogg-dube syndrome, cutaneous leiomyoma, cutaneous leiomyomata with uterine leiomyomata, familial renal cancer, fh gene mutation, flcn gene mutation, hlrcc, kidney cancer, met gene mutation, renal cell carcinoma, renal tumor histology, vhl syndrome